ASAP announces new teams joining the Collaborative Research Network! Learn More
Aligning Science Across Parkinson's Logo Text
Submit site search
  • SINTBAD-GFP: expression and purification

    By on

    This protocol describes how to express and purify human SINTBAD tagged C-terminally with eGFP.

  • 2BT-His-TEV-cs-ATG3_C264S

    By on

    DISCONTINUED - Plasmid for bacterial Expression of human ATG3 C264S.

  • Immunological detection of autophagy and mTORC1-related proteins

    By on

    A general protocol for immunological detection by Western blotting MTOR, MTOR (pS2448), ULK1, ULK1 (pS757), p70S6K, p70S6K (pT389), SQSTM1, CALCOCO2, MAP1LC3B, GABARAP, TFEB, TFE3, PGRN, HSP90, and PCNA.

  • pCMV-DNAJC5-L116Δ

    By on

    Mammalian expression of DNAJC5 L116Δ

  • Headplate surgery protocol for in vivo electrophysiological and optogenetic manipulation of basal ganglia neurons in awake head-fixed mice

    By on

    Step by step protocol for headplate surgery for in vivo electrophysiological and optogenetic manipulation of basal ganglia neurons in awake mice.

  • pCAG-BECN1

    By on

    Plasmid for Mammalian expression of BECN1.

  • Evaluation of a novel method for spectral analysis of neurophysiology data

    By on

    This code implements a novel method for correcting a distortion effect that is present in the power spectra of neuronal spike trains.

  • pCAG-MBP-ATG9 (801-839)

    By on

    Plasmid: To make monomeric ATG9 C-terminal tail for expression in mammalian cells.

  • Damaged mitochondria recruit the effector NEMO to activate NF-κB signaling

    By on

    The connections between molecular mechanisms like mitophagy and tissue-wide features like neuro-inflammation remain unclear. Here, the authors characterize a novel link between these two hallmarks of neurodegeneration.

  • Mitochondrial isolation protocol

    By on

    This protocol describes how to isolate crude mitochondrial fractions from HeLa cells.

  • α-synuclein promotes neuronal dysfunction and death by disrupting the binding of ankyrin to ß-spectrin

    By on

    α-synuclein plays a key role in the pathogenesis of Parkinson’s disease and related disorders, but critical interacting partners and molecular mechanisms mediating neurotoxicity are incompletely understood. We show that α-synuclein binds directly to ß-spectrin. Using males and females in a Drosophila model of α-synuclein-related disorders we demonstrate that ß-spectrin is critical for α-synuclein neurotoxicity. Further, the ankyrin binding domain of ß-spectrin is required for α-synuclein binding and neurotoxicity. A key plasma membrane target of ankyrin, Na+/K+ ATPase, is mislocalized when human α-synuclein is expressed in Drosophila. Accordingly, membrane potential is depolarized in α-synuclein transgenic fly brains. We examine the same pathway in human neurons and find that Parkinson’s disease patient-derived neurons with a triplication of the α-synuclein locus show disruption of the spectrin cytoskeleton, mislocalization of ankyrin and Na+/K+ ATPase, and membrane potential depolarization. Our findings define a specific molecular mechanism by which elevated levels of α-synuclein in Parkinson’s disease and related α-synucleinopathies leads to neuronal dysfunction and death.

  • GFP Immunoprecipitation and Sample Preparation for Tandem Mass Tag (TMT) Mass Spectrometry Analysis

    By on

    We describe a method to identify potential interactors of any Green Fluorescent Protein (GFP) tagged protein expressed in mammalian cells by GFP immunoprecipitation coupled to Tandem Mass Tag (TMT) mass spectrometry analysis. As an example, we used a GFP-tagged phosphoRab interactor protein (RILPL1-GFP), and its non-binding mutant (RILPL1 -GFP, which cannot interact with phosphorylated Rab proteins) as a control.

  • Three-step docking by WIPI2, ATG16L1 and ATG3 delivers LC3 to the phagophore

    By on

    In this manuscript, in a near-complete pathway from initial membrane recruitment to LC3 lipidation reaction, we show how a three-step targeting mechanism of the ATG12-ATG5-ATG16L1 machinery ensures a high level of regulatory control on autophagy.

  • ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization

    By on

    ATP13A2 loss-of-function mutations are linked to Parkinson’s disease and alpha-synuclein pathology. The authors found that loss of ATP13A2 disrupts lysosomal membrane integrity and causes alpha-synuclein multimerization.

  • Constructs and generation of stable cell lines

    By on

    Protocol used to generate stable Flp-In T-REx-HEK 293 cell lines expressing WT or mutant GCase (E326K or L444P) as a V5-FLAG-tagged protein using a tetracycline-inducible system.

  • pCAG-mcherry- WIPI2dR125E- cs-TEV -STREP

    By on

    Plasmid for mammalian expression of human WIPI2d R125E with N-terminal mCherry and C-terminal Strep.

  • His-ATG3

    By on

    Plasmid for ATG3 wild type mutant overexpression in E.Coli.

  • Local diffusion in the extracellular space of the brain

    By on

    The authors highlight emerging technological advances to respectively interrogate and model diffusion through the ECS, and point out how these may contribute in resolving the remaining enigmas of the ECS.

  • H9 ES AAVS1-NGN2 FAM134B-/-

    By on

    Cell Line: ES cells for making iNeurons lacking the ER-phagy receptor FAM134B.

  • BFP-Rab5CA (Q79L)

    By on

    Mammalian expression of BFP-tagged mutant Rab5CA

Load More
Aligning Science Across Parkinson's
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.